Biopharma Business

Report highlights economic benefits of UK life sciences

 Breaking News

Report highlights economic benefits of UK life sciences

March 06
14:20 2017

The report, commissioned by the Association of the British Pharmaceutical Industry (ABPI) and supported by the Association of the British Healthcare Industry (ABHI), the BioIndustry Association (BIA), and the British In Vitro Diagnostics Association (BIVDA), shows that the average productivity of UK life sciences employees is £104,000 compared to the UK Gross Value Added (GVA) average of £49,000.

In 2015 UK life sciences contributed £30.7 billion to the economy providing an estimated tax contribution of £8.6 billion to the exchequer.

The sector supports a total of 482,000 jobs in the UK, with every life sciences job supporting 2.5 jobs elsewhere.

Dr. Virginia Acha, ABPI executive director, Research, Medical and Innovation, said: “The Life Sciences sector has been recognised by the prime minister as being of strategic importance for the UK. In both the UK and global healthcare markets, the sector plays a vital role in helping to tackle long-term health challenges. This report reflects, for the first-time, how our sector also plays a vital role in contributing to the UK economy.

The UK’s productivity problem is well-known, and whether in advanced medicines manufacturing, med-tech or world-leading biopharma R&D, this report emphasises the true value UK Life Sciences has to offer. If we are serious about improving our productivity, increasing public and private investment in science and innovation across the UK will be a fundamental piece of the puzzle.”

Jo Pisani, partner at PwC and author of the report, said: “PwC are pleased to support the UK Life Sciences Industry by producing this important report. The sector is a major contributor to employment, taxes and GDP – providing high skilled and highly productive jobs across the UK.”

About Author



Related Articles

Upcoming Events


The Magazine

New Subscriber

Subscribe Here